title: Increased apoptosis in cervical intraepithelial neoplasia associated with HIV infection: implication of oncogenic human papillomavirus, caspases, and Langerhans cells.
abstract: OBJECTIVE
  Increasing risk of squamous cervical intraepithelial neoplasia (CIN) exits in HIV-infected women. However, the relatively low incidence of invasive carcinoma in the untreated HIV-infected population suggests an imbalance between cell proliferation and apoptosis. We investigated apoptosis and caspases in cervical samples from this population comparatively to non-HIV-infected and control subjects.
  
  
  METHODS
  Apoptotic terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling method, immunohistochemistry for caspase-2, caspase-3, caspase-8, caspase-9, and other apoptosis markers were done on 12 normal cervical samples and 103 low- and high-grade cervical lesions, containing human papillomavirus(es) from 35 HIV-negative and 33 HIV-positive women before tritherapy advent.
  
  
  RESULTS
  (a) The apoptotic index (AI) in epithelial cells did not vary between normal mucosa and condyloma acuminata infected or not with HIV. (b) AI augmented with the CIN severity in HIV-positive and HIV-negative women. (c) AI dramatically increased in oncogenic human papillomavirus-infected CIN of HIV-positive population compared with the CIN of similar grade in HIV-negative one. This was associated with a greater expression of caspase-8, active caspase-9, and active caspase-3 in those samples. Moreover, densities of Langerhans' cells, involved in apoptotic bodies engulfment, were greatly reduced in CIN of HIV-positive women. In samples, these densities were highly inversely correlated with AI (r = -0.88, P < 0.002).
  
  
  CONCLUSIONS
  This study provides the first evidence for the strongly enhanced apoptosis levels and caspase expression in CIN of untreated HIV-infected women. We suggest that the reduction in Langerhans' cell number could contribute at least partly to apoptotic cell accumulation.
authors.affiliation: Department of Pathology, INSERM LL683, IFR2 Physiologie et Pathophysiologie, Paris, France. francine.walker@bch.ap-hop.paris.fr
authors.forename: Francine
authors.initials: F
authors.lastname: Walker
authors.forename: Homa
authors.initials: H
authors.lastname: Adle-Biassette
authors.forename: Patrick
authors.initials: P
authors.lastname: Madelenat
authors.forename: Dominique
authors.initials: D
authors.lastname: Hénin
authors.forename: Thérèse
authors.initials: T
authors.lastname: Lehy
mesh_terms: D018949:Antigens, CD1 / Q000032:analysis; D017209:Apoptosis; D020169:Caspases / Q000378:metabolism; D004848:Epithelium / Q000378:metabolism / Q000473:pathology / Q000821:virology; D005260:Female; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D007150:Immunohistochemistry; D007801:Langerhans Cells / Q000378:metabolism / Q000473:pathology / Q000821:virology; D009092:Mucous Membrane / Q000378:metabolism / Q000473:pathology / Q000821:virology; D027383:Papillomaviridae; D030361:Papillomavirus Infections / Q000378:metabolism / Q000473:pathology / Q000821:virology; D002583:Uterine Cervical Neoplasms / Q000150:complications / Q000473:pathology*; D002578:Uterine Cervical Dysplasia / Q000150:complications / Q000473:pathology*
chemical_list: D018949:Antigens, CD1; C419393:CD1a antigen; D020169:Caspases